Nearmap Ltd (ASX: NEA) shares leapt 8.5% after the aerial imaging business announced its preliminary half-year results.
Nearmap is a leader of aerial imagery technology and location data, providing frequently-updated, high-resolution aerial imagery. Basically, it takes high-resolution photos from a plane.
Why Nearmap Shares Jumped
Nearmap announced that in the first half of its 2019 financial year its annualised contract value (ACV) increased by 42% year on year to $78.3 million, with 107% growth in the US business to US$17.6 million and 23% growth in Australia to $53.3 million.
Management attributed the US performance to a focus on sales & marketing. Nearmap touted clear product advantages and functionality which drove high market awareness and customer traction.
Nearmap is planning expansion into Canada during the 2019 calendar year and is also planning expanded products and content. To fund its plans, Nearmap finished December 2018 with $81.3 million in cash and reaffirmed guidance for FY19 to be cash flow breakeven even excluding the capital raise.
Dr Rob Newman, the Nearmap CEO and Managing Director, said:
“Our Australian business is building on its market leadership and our US business is gaining significant market traction. We are well placed to deliver ongoing growth as new product enhancements add functionality, and our markets continue to develop and expand.”
Is It Time to buy Nearmap Shares?
The prospect of good growth, Canada expansion and cashflow breakeven seem to have excited investors today.
To be frank, I’m not sure how good of an opportunity Nearmap shares are right now, so you should do some extra research if you’re interested in its shares. However, Nearmap isn’t the only ASX small-cap company generating blistering growth. For example, the two shares in the free report below are also worth looking at.
2 Rapid Growth Shares For 2019
After searching through a market with over 2,000 shares, our expert investment analyst has narrowed it down to just 2 of his favourite rapid-growth shares in a FREE report to Rask Media readers.
Over the past five years, these two shares have gone from being 'tiny caps' to being serious contenders for the ASX 200.
Idea #1 is taking on the world, starting with the huge USA market. In a just a few short years the company has snatched market share away from rivals and is on its way to being the market leader.
Idea #2 uses a 'printer and cartridge' type model to get large and established customers: a) using their healthcare industry-leading product, b) paying for it again and again and again... so it's little wonder this company is tipped to grow at a rapid pace in 2019.
Access the free report by clicking here now. Absolutely no credit card or payment details required.
Disclaimer: Any information contained in this article is limited to general financial/investment advice only. The information has not taken into account your specific needs, goals or objectives, so please consider consulting a licenced and trusted adviser before acting on the information. Please read The Rask Group’s Financial Services Guide (FSG) for more information. This article is authorised by Owen Raszkiewicz of The Rask Group, which is a corporate authorised representative No. 1264179 of Strawman Pty Ltd (ACN: 610 908 211) (AFSL: 501 223).